LG00034053
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LG00034053, covering 2024-05-03 to 2024-05-03. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of LG00034053 in Patients With Knee OA [Phase 1, Phase 2]